CORT
$110.29
▼ −3.98%09/18 O 116.80 H 117.90 L 108.41 C 110.29 ▼ −3.98%
Vol 17.2M RS 96
Vol 17.2M RS 96
RS rating96
Now vs pivot (%)−9.75%
Tightening (ATR ratio)2.26×
Volume dry-up2.22×
Up/down volume, net-0.20
From 52-week high13%
played out
Corcept Therapeutics Inc.
CORT · Pharmaceutical Preparations · $11.9B
Powering up
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
The four are not in order. That is a description of where the averages sit, not a view about what happens next.
The read
The base has run 3.2 weeks and fell 14% from its ceiling at its deepest. The pivot is $122.21, and the stock closed 9.8% below it. Its relative strength rating is 96.
Also on
Peers
Catalyst roadmap
- EarningstentativeLLY · competitorin 41dLLY reportsOct 29, 2026
- Earningstentativein 47dQuarterly earningsNov 4, 2026
Flagged by the market sweep
Several insiders soldInsider · 2026-09-18
6 insiders sold $30,972,291
Several insiders soldInsider · 2026-09-17
6 insiders sold $30,972,291
Several insiders soldInsider · 2026-09-16
4 insiders sold $28,730,404
Several insiders soldInsider · 2026-09-15
4 insiders sold $28,730,404
Several insiders soldInsider · 2026-09-12
4 insiders sold $28,730,404
Several insiders soldInsider · 2026-09-11
4 insiders sold $28,730,404
From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.
In the news
No headlines for this company in the last couple of weeks.
Insiders
No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.
X-ray